Acute and recurrent pericarditis

Česká verzia

Authors: Tomáš Paleček
Authors place of work: II. interní klinika – klinika kardiologie a angiologie 1. LF UK a VFN v Praze
Published in the journal: Vnitř Lék 2019; 65(10): 624-629
Category:

Summary

Pericardial diseases have been until recently relatively neglected entity; however, there has been a markedly increased interest in these disorders in the last decade due to new diagnostic as well as therapeutic options. Various clinical manifestations of pericardial diseases may be generally grouped into pericardial syndromes including pericarditis, pericardial effusion, cardiac tamponade and constrictive pericarditis. In this review, the comprehensive analysis of acute and recurrent pericarditis is presented. Acute and recurrent pericarditis represent the most common pericardial disorders in clinical practice, in which major changes in therapeutic procedures occurred based on recently published trials, particularly the introduction of colchicine therapy.

Keywords:

magnetic resonance – acute pericarditis – colchicine – pericardial effusion – recurrent pericarditis

Zdroje

Sheith S, Wang DD, Kasapis C. Current and emerging strategies for the treatment of acute pericarditis: a systematic review. J Inflamm Res 2010; 3: 135–142. Dostupné z DOI: <http://dx.doi.org/10.2147/JIR.S10268>.
Troughton RW, Asher CR, Klein AL. Pericarditis. Lancet 2004; 363(9410): 717–727. Dostupné z DOI: <http://dx.doi.org/10.1016/S0140–6736(04)15648–1>.
Maisch B, Seferović PM, Ristić AD et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 2004; 25(7): 587–610. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ehj.2004.02.002>.
Adler Y, Charron P, Imazio M et al. 2015 Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2015; 36(42): 2921–2964. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehv318>.
Imazio M. Pericardial involvement in systemic inflammatory diseases. Heart 2011; 97(22): 1882–1892. Dostupné z DOI: <http://dx.doi.org/10.1136/heartjnl-2011–300054>.
Gunukula SR, Spodick DH. Pericardial disease in renal patients. Semin Nephrol 2001; 21(1): 52–56.
Renfrew R, Buselmeier TJ, Kjellstrand CM. Pericarditis and renal failure. Annu Rev Med 1980; 31: 345–360. Dostupné z DOI: <http://dx.doi.org/10.1146/annurev.me.31.020180.002021>.
Imazio M. Contemporary management of pericardial diseases. Curr Opin Cardiol 2012; 27(3): 308–317. Dostupné z DOI: <http://dx.doi.org/10.1097/HCO.0b013e3283524fbe>.
Spodick DH. Electrocardiogram in acute pericarditis. Distributions of morphologic and axial changes by stages. Am J Cardiol 1974; 33(4): 470–474. Dostupné z DOI: <http://dx.doi.org/10.1016/0002–9149(74)90603–1>.
Klein AL, Abbara S, Agler DA et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr 2013; 26(9): 965–1012. Dostupné z DOI: <http://dx.doi.org/10.1016/j.echo.2013.06.023>.
Dudzinski DM, Mak GS, Hung JW. Pericardial Diseases. Curr Probl Cardiol 2012; 37(3): 75–118. Dostupné z DOI: <http://dx.doi.org/10.1016/j.cpcardiol.2011.10.002>.
Imazio M, Bobbio M, Cecchi E et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation 2005; 112(13): 2012–2016. Dostupné z DOI: <http://dx.doi.org/10.1161/CIRCULATIONAHA.105.542738>.
Imazio M, Brucato A, Cemin R et al. A randomized trial of colchicine for acute pericarditis. N Engl J Med 2013; 369(16): 1522–1528. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1208536>.
Maisch B, Ristic AD, Pankuweit S. Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone: the way to avoid side effects of systemic corticosteroid therapy. Eur Heart J 2002; 23(19): 1503–1508. Dostupné z DOI: <http://dx.doi.org/10.1053/euhj.2002.3152>.
Imazio M, Trinchero R, Brucato A et al. COlchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial. Eur Heart J 2010; 31(22): 2749–2754. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehq319>.
Imazio M, Spodick DH, Brucato A et al. Controversial issues in the management of pericardial diseases. Circulation 2010; 121(7): 916–928. Dostupné z DOI: <http://dx.doi.org/10.1161/CIRCULATIONAHA.108.844753>.
Imazio M, Trinchero R, Shabetai R. Pathogenesis, management, and prevention of recurrent pericarditis. J Cardiovasc Med 2007; 8(6): 404–410. Dostupné z DOI: <http://dx.doi.org/10.2459/01.JCM.0000269708.72487.34>.
Imazio M, Brucato A, Cemin R et al. Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med 2011; 155(7): 409–414. Dostupné z DOI: <http://dx.doi.org/10.7326/0003–4819–155–7-201110040–00359>.
Imazio M, Brucato A, Trinchero R et al. Corticosteroid therapy for pericarditis: a double-edged sword. Nat Clin Pract Cardiovasc Med 2008; 5(3): 118–119. Dostupné z DOI: <http://dx.doi.org/10.1038/ncpcardio1094>.